Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Apr 8;24(6):962–968. doi: 10.1158/1055-9965.EPI-14-1429

Table 3.

Multivariable* Relative Risks of Breast Cancer by AR Status According to Physical Activity in the Nurses’ Health Study (1986–2006).

Overall invasive
breast cancer
(n=5,410)
Not accounting for ER/PR status Accounting for ER/PR status


Physical activity
(MET-hrs/wk)
AR+ (n=1,661) AR− (n=467) P-
het
AR+ (n=1,661) AR− (n=467) P-
het
  <3 1.0 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
  3–<9 0.99 (0.91, 1.08) 0.95 (0.82, 1.11) 0.99 (0.74, 1.32) 0.95 (0.81, 1.11) 0.99 (0.71, 1.38)
  9–<18 0.93 (0.85, 1.02) 0.88 (0.75, 1.03) 1.10 (0.83, 1.47) 0.84 (0.72, 0.99) 1.16 (0.83, 1.60)
  18–<27 0.94 (0.85, 1.03) 0.91 (0.76, 1.09) 0.97 (0.70, 1.36) 0.90 (0.75, 1.08) 1.04 (0.71, 1.51)
  ≥ 27 0.86 (0.78, 0.95) 0.89 (0.75, 1.06) 0.74 (0.52, 1.04) 0.34 0.85 (0.71, 1.01) 0.73 (0.49, 1.07) 0.47
p-trend <0.001 0.21 0.08 0.12 0.05
Per 20 MET-hrs/wk (equivalent to 5 hours of brisk walking per week) 0.89 (0.81, 0.98) 0.83 (0.70, 0.98) 0.67 (0.47, 0.95) 0.28 0.87 (0.73, 1.04) 0.67 (0.45, 0.99) 0.22
*

MV-Adjusted for age at menarche, body mass index at age 18 years, height, parity and age at first birth, alcohol intake, postmenopausal hormone use, age at menopause, family history of breast cancer, and history of benign breast disease.

p-value for heterogeneity between AR+ and AR− tumors.